Here's some "fundamentals." The O/S is up 100M shares already since the end of September, and all the convertible notes and those convertible Preferred B shares (at 3000:1) are set to get dumped in. This is excerpted from the last quarterly report, page 18.
Tekumo Contribution Agreement and Reorganization On June 14, 2022, Balincan entered into a Contribution Agreement with Tekumo LLC (“Tekumo”), a Colorado limited liability corporation, in which it acquired 100% of the membership interests of Tekumo in exchange for ten million (10,000,000) shares of a newly designated Series A Preferred Stock. The Series A Preferred Stock is senior to all other classes of stock and represents 85% of the voting control of the Company and may be converted into 85% of the Company’s fully diluted common stock, non-dilutive for a period of eighteen months. In conjunction with the change of control, the Company also issued one million (1,000,000) shares of a newly designated Series B Preferred Stock as consideration for services rendered pursuant to a third-party consulting agreement. The Series B Preferred stock is junior to the Series A Preferred Stock upon liquidation, but is senior to all other classes of stock, is non-voting, and may be converted into 9.99% of the Company’s fully diluted common stock, non-dilutive for a period of eighteen months. The Company also issued a total of $797,500 in Convertible Notes pursuant to Security Purchase Agreements. The Notes may convert into 159,500,000 common shares. The Convertible Notes are accompanied by 7-year Warrants that may be exercised into 145,000,000 common shares. To effect the reverse merger, consideration of 53,318,141 shares of the Company’s common stock were retained. This is inclusive of the prior Series A Preferred Stock and Series C Preferred Stock along with $375,000 of unsecured Notes that were all converted into common stock. The Company and a voting majority of its shareholders approved an amendment to the Company’s Articles of Incorporation whereby the number of authorized shares of common stock was increased to 1.5 billion shares. On September 30, 2022, the Company issued $660,000 in Convertible Notes pursuant to Security Purchase Agreements. The Notes may convert into 132,000,000 common shares. The Convertible Notes are accompanied by 7- year Warrants that may be exercised into 120,000,000 common shares. Recent Recapitalization On June 15, 2023 the Company issued a total of $203,500 in Convertible Notes with a 1-year maturity. The Notes may convert into common shares at a variable conversion price equal to 50% of the common share market price. The Convertible Notes are accompanied by 7-year Warrants that may be exercised into 185,000,000 common shares. On September 15, 2023, the Circuit Court of Baltimore County, Maryland (the “Court’) rendered an order approving a Settlement Agreement and Stipulation between Trillium Partners LP (“Trillium”) and the Company for the payment of $2,255,121.18 in past due debt obligations originally issued or assigned to Trillium (the “3(a)(10) Settlement”). Under the terms of the agreement, Trillium may convert the debt into shares of common stock at a price equal to the lowest trading price during the thirty (30) trading day period prior to any conversion, subject to a 9.99% limitation on beneficial ownership at the time such conversion. A Remittance Amount of 66.67% of the Net Proceeds from the sale of the Settlement Shares shall reduce the balance of the Notes outstanding. The conversion shares issued by the Company will be unrestricted in reliance on Section 3(a)(10) of the Securities Act of 1933. The Company and a voting majority of its shareholders approved an amendment to the Company’s Articles of Incorporation on October 4 whereby the number of authorized shares of common stock was increased to 5 billion shares.